Ji Xiong1,2, Wenli Tan3, Jianbo Wen1, Jiawei Pan1, Yin Wang2, Jun Zhang4, Daoying Geng5. 1. Department of Radiology, Huashan Hospital of Fudan University, No. 12 the Middle Wu Lu Mu Qi Road, Shanghai, 200040, China. 2. Department of Neuropathology, Huashan Hospital of Fudan University, Shanghai, China. 3. Department of Radiology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. 4. Department of Radiology, Huashan Hospital of Fudan University, No. 12 the Middle Wu Lu Mu Qi Road, Shanghai, 200040, China. zhj81828@163.com. 5. Department of Radiology, Huashan Hospital of Fudan University, No. 12 the Middle Wu Lu Mu Qi Road, Shanghai, 200040, China. daoyinggeng@163.com.
Abstract
OBJECTIVES: To explore the correlations of conventional MRI (cMRI) and diffusion tensor imaging (DTI) values with the 1p/19 codeletion and IDH mutations in oligodendroglial tumours (OTs). METHODS: Eighty-four patients with OTs who underwent cMRI and DTI were retrospectively reviewed. The maximal fractional anisotropy and minimal apparent diffusion coefficient (ADC) were measured and compared using the Mann-Whitney U test. Receiver operating characteristic curves, logistic regression analysis and four-table statistics analysis were performed to predict genotypings. RESULTS: OTs with 1p/19q codeletion or IDH mutations were prone to locate in frontal (P = 0.106 and 0.005, respectively) and insular lobes and were associated with absent or blurry contrast enhancement (P = 0.040 and 0.013, respectively). DTI values showed significant differences between OTs with and without IDH mutations (P < 0.05) but not in OTs with and without 1p/19q loss. The Ki-67 index significantly correlated with IDH mutations (P = 0.002) but not with 1p/19q codeletion. A combination of DTI and cMRI for the identification of IDH mutations resulted in sensitivity, specificity, positive and negative predictive values of 92.2 %, 75.8 %, 93.8 % and 71.1 %, respectively. CONCLUSIONS: Combination of DTI and cMRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in OTs. KEY POINTS: • OTs with 1p/19q codeletion were associated with absent or blurry contrast enhancement • OTs with IDH mutations were also associated with absent or blurry contrast enhancement • OTs with IDH mutations were prone to locate in frontal and insular lobes • DTI values can provide a non-invasive method for assessing the IDH status of OTs • A combination of DTI and cMRI correlates with isocitrate dehydrogenase 1/2 mutations.
OBJECTIVES: To explore the correlations of conventional MRI (cMRI) and diffusion tensor imaging (DTI) values with the 1p/19 codeletion and IDH mutations in oligodendroglial tumours (OTs). METHODS: Eighty-four patients with OTs who underwent cMRI and DTI were retrospectively reviewed. The maximal fractional anisotropy and minimal apparent diffusion coefficient (ADC) were measured and compared using the Mann-Whitney U test. Receiver operating characteristic curves, logistic regression analysis and four-table statistics analysis were performed to predict genotypings. RESULTS: OTs with 1p/19q codeletion or IDH mutations were prone to locate in frontal (P = 0.106 and 0.005, respectively) and insular lobes and were associated with absent or blurry contrast enhancement (P = 0.040 and 0.013, respectively). DTI values showed significant differences between OTs with and without IDH mutations (P < 0.05) but not in OTs with and without 1p/19q loss. The Ki-67 index significantly correlated with IDH mutations (P = 0.002) but not with 1p/19q codeletion. A combination of DTI and cMRI for the identification of IDH mutations resulted in sensitivity, specificity, positive and negative predictive values of 92.2 %, 75.8 %, 93.8 % and 71.1 %, respectively. CONCLUSIONS: Combination of DTI and cMRI correlates with isocitrate dehydrogenase 1/2 mutations but not 1p/19q genotyping in OTs. KEY POINTS: • OTs with 1p/19q codeletion were associated with absent or blurry contrast enhancement • OTs with IDH mutations were also associated with absent or blurry contrast enhancement • OTs with IDH mutations were prone to locate in frontal and insular lobes • DTI values can provide a non-invasive method for assessing the IDH status of OTs • A combination of DTI and cMRI correlates with isocitrate dehydrogenase 1/2 mutations.
Authors: Michael D Jenkinson; Daniel G du Plessis; Trevor S Smith; Kathy A Joyce; Peter C Warnke; Carol Walker Journal: Brain Date: 2006-05-02 Impact factor: 13.501
Authors: S Fellah; D Caudal; A M De Paula; P Dory-Lautrec; D Figarella-Branger; O Chinot; P Metellus; P J Cozzone; S Confort-Gouny; B Ghattas; V Callot; N Girard Journal: AJNR Am J Neuroradiol Date: 2012-12-06 Impact factor: 3.825
Authors: Michael D Jenkinson; Trevor S Smith; Andrew R Brodbelt; Kathy A Joyce; Peter C Warnke; Carol Walker Journal: J Magn Reson Imaging Date: 2007-12 Impact factor: 4.813
Authors: J S Frenel; C Leux; D Loussouarn; A-G Le Loupp; F Leclair; M Aumont; A Mervoyer; S Martin; M G Denis; M Campone Journal: J Neurooncol Date: 2013-05-17 Impact factor: 4.506
Authors: Shanshan Jiang; Tianyu Zou; Charles G Eberhart; Maria A V Villalobos; Hye-Young Heo; Yi Zhang; Yu Wang; Xianlong Wang; Hao Yu; Yongxing Du; Peter C M van Zijl; Zhibo Wen; Jinyuan Zhou Journal: Magn Reson Med Date: 2017-07-16 Impact factor: 4.668
Authors: Eric Aliotta; Prem P Batchala; David Schiff; Beatriz M Lopes; Jason T Druzgal; Sugoto Mukherjee; Sohil H Patel Journal: J Neurooncol Date: 2019-09-17 Impact factor: 4.130
Authors: E Aliotta; H Nourzadeh; P P Batchala; D Schiff; M B Lopes; J T Druzgal; S Mukherjee; S H Patel Journal: AJNR Am J Neuroradiol Date: 2019-08-14 Impact factor: 3.825
Authors: P Chang; J Grinband; B D Weinberg; M Bardis; M Khy; G Cadena; M-Y Su; S Cha; C G Filippi; D Bota; P Baldi; L M Poisson; R Jain; D Chow Journal: AJNR Am J Neuroradiol Date: 2018-05-10 Impact factor: 3.825